Target Lubricant Eye Drops Recalled for Non-Sterility
Target brand High Performance Lubricant Eye Drops have been recalled nationwide due to non-sterility. The manufacturer, Kilitch Healthcare India Limited, initiated the voluntary FDA Class I recall affecting 401,568 bottles.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall, which requires a minimum severity score of 4. While no deaths or reported illnesses are mentioned in the source, non-sterility in eye drops presents a significant risk of infection.
Plain-English summary
Target brand High Performance Lubricant Eye Drops in 0.5 FL OZ (15 mL) bottles are being recalled. The affected products include both single pack (NDC 11673-522-15) and twin pack (NDC 11673-522-30) configurations. All lots are subject to the recall, affecting 401,568 bottles total.
The reason for the recall is non-sterility. Manufacturer Kilitch Healthcare India Limited voluntarily initiated this FDA Class I recall on November 13, 2023. The product was distributed nationwide within the United States by Target Corporation, Minneapolis, MN 55403.
The recall remains ongoing.
The recalled product
- Product
- Target brand High Performance Lubricant Eye Drops (Polyethylene glycol 400 0.4%, Propylene glycol 0.3%) a) 0.5 FL OZ (15mL) bottles (Single Pack) (NDC 11673-522-15) and b) 0.5 FL OZ (15 mL) bottles (Twin pack) (NDC 11673-522-30), Distributed by: Target Corporation Minneapolis, MN
- Manufacturer
- Kilitch Healthcare India Limited
- Category
- Drug — Lubricant Eye Drops
- Hazard
- non-sterility
- microbial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27